Table 4.
Overall cardiovascular adverse events |
Overall respiratory adverse events |
|||
---|---|---|---|---|
OR (95% CI) | p-value | OR (95% CI) | p-value | |
Age, yr | 1.02 (0.93–1.11) | 0.730 | 0.93 (0.82–1.05) | 0.219 |
Sex | ||||
Male | 1 | 1 | ||
Female | 1.65 (0.37–7.29) | 0.511 | 15.73 (0.69–359.76) | 0.084 |
BMI | 1.22 (1.02–1.46) | 0.030 | 0.96 (0.74–1.25) | 0.746 |
Alcohol | 3.03 (0.77–11.96) | 0.113 | 0.48 (0.05–4.99) | 0.541 |
Smoking | 0.85 (0.29–2.46) | 0.758 | 2.98 (0.39–22.93) | 0.295 |
Total procedure time | 1.10 (0.78–1.55) | 0.600 | 1.17 (0.62–2.20) | 0.635 |
Sedative | ||||
Etomidate | 1 | 1 | ||
Midazolam | 2.96 (0.68–12.94) | 0.150 | 0.12 (0.01–1.59) | 0.108 |
Propofol | 0.78 (0.16–3.89) | 0.762 | 0.52 (0.09–2.88) | 0.453 |
BMI, body mass index; CI, confidence interval; OR, odds ratio.